Header Logo

Connection

Yuki Kageyama to Dacarbazine

Back to Details
This is a "connection" page, showing publications Yuki Kageyama has written about Dacarbazine.
Yuki Kageyama
Connection Strength
0.037
Dacarbazine
  1. Successful treatment of primary bone marrow Hodgkin lymphoma with brentuximab vedotin: a case report and review of the literature. J Med Case Rep. 2018 May 30; 12(1):151.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.